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Abstract
Background: Neuronal and glial differentiation in the murine hypothalamus is not complete at birth, but continues
over the first two weeks postnatally. Nutritional status and Leptin deficiency can influence the maturation of neuronal
projections and glial patterns, and hypothalamic gliosis occurs in mouse models of obesity. Gnasxl constitutes
an alternative transcript of the genomically imprinted Gnas locus and encodes a variant of the signalling protein Gαs,
termed XLαs, which is expressed in defined areas of the hypothalamus. Gnasxl-deficient mice show postnatal growth
retardation and undernutrition, while surviving adults remain lean and hypermetabolic with increased sympathetic
nervous system (SNS) activity. Effects of this knock-out on the hypothalamic neural network have not yet
been investigated.
Results: RNAseq analysis for gene expression changes in hypothalami of Gnasxl-deficient mice indicated Glial
fibrillary acid protein (Gfap) expression to be significantly down-regulated in adult samples. Histological analysis
confirmed a reduction in Gfap-positive glial cell numbers specifically in the hypothalamus. This reduction was
observed in adult tissue samples, whereas no difference was found in hypothalami of postnatal stages, indicating an
adaptation in adult Gnasxl-deficient mice to their earlier growth phenotype and hypermetabolism. Especially noticeable
was a loss of many Gfap-positive α-tanycytes and their processes, which form part of the ependymal layer that lines
the medial and dorsal regions of the 3rd ventricle, while β-tanycytes along the median eminence (ME) and infundibular
recesses appeared unaffected. This was accompanied by local reductions in Vimentin and Nestin expression.
Hypothalamic RNA levels of glial solute transporters were unchanged, indicating a potential compensatory up-
regulation in the remaining astrocytes and tanycytes.
Conclusion: Gnasxl deficiency does not directly affect glial development in the hypothalamus, since it is expressed in
neurons, and Gfap-positive astrocytes and tanycytes appear normal during early postnatal stages. The loss of
Gfap-expressing cells in adult hypothalami appears to be a consequence of the postnatal undernutrition, hypoglycaemia
and continued hypermetabolism and leanness of Gnasxl-deficient mice, which contrasts with gliosis observed in obese
mouse models. Since α-tanycytes also function as adult neural progenitor cells, these findings might indicate
further developmental abnormalities in hypothalamic formations of Gnasxl-deficient mice, potentially including
neuronal composition and projections.
Keywords: Gnas, Genomic imprinting, Hypothalamus, Tanycyte, Gfap, Glia, Energy homoeostasis, RNAseq
* Correspondence: jp@senescence.info; a.plagge@liverpool.ac.uk
1Integrative Genomics of Ageing Group, Institute of Integrative Biology,
University of Liverpool, Crown Str, Liverpool L69 7ZB, UK
2Cellular and Molecular Physiology, Institute of Translational Medicine,
University of Liverpool, Crown Str, Liverpool L69 3BX, UK
© 2016 Holmes et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Holmes et al. Molecular Brain  (2016) 9:39 
DOI 10.1186/s13041-016-0219-1
Background
The hypothalamus exerts important regulatory functions
in whole-body energy homeostasis, including food intake,
energy expenditure and SNS activity [1–3]. A neuronal
network between several hypothalamic nuclei, including
the arcuate nucleus (Arc), dorsomedial nucleus (DMH)
and paraventricular nucleus (PVH), integrates peripheral
hormonal signals like leptin, insulin and ghrelin, which re-
flect levels of energy reserves and feeding status. The
pathways of leptin action, to inhibit food intake and
stimulate energy expenditure when adipose tissue fat
reserves are high, have been elucidated in some detail.
Leptin inhibits orexigenic neuropeptide Y (NPY) neurons
and activates anorexigenic pro-opiomelanocortin (POMC)
neurons in the arcuate nucleus [3]. This leads to activation
of the melanocortin system (neurons expressing MC4 and
MC3 receptors) in the PVH, parabrachial nucleus, dorsal
vagal complex and the intermediolateral cell column of
the spinal cord. While MC4R-expressing neurons in the
PVH and parabrachial nucleus mainly regulate food in-
take, those in other hypothalamic nuclei, the dorsal vagal
complex and the spinal cord have been implicated in the
control of energy expenditure and SNS activity [1–3].
In rodents, the formation of the hypothalamic neural
network is incomplete at birth as, for example, axonal
projections from the Arc to the PVH and DMH develop
and mature over the first two weeks postnatally [4–6].
Leptin has an important neurotrophic function during
this postnatal period. Deficiency of leptin results in di-
minished POMC and NPY/Agrp projections from the
Arc [4]. Full functionality of the neuronal circuits
controlling food intake and energy expenditure is estab-
lished by weaning age. Apart from leptin deficiency,
nutritional status at embryonic or postnatal stages can
also impact on the formation of neural circuits control-
ling energy homeostasis [5, 7]. Perturbations during
these developmental stages do not always lead to obesity
as, for example, postnatal undernutrition results in per-
manent leanness, transformation of white to brown-like
adipose tissue, increased hypothalamic leptin and mela-
nocortin sensitivity and increased leptin receptor expres-
sion [8–10]. The changes in molecular mechanisms and
neural networks leading to such permanent leanness
have not yet been investigated in detail.
Apart from neuronal networks, glial cells and tany-
cytes, which are located within the ependymal layer of
the 3rd ventricle, also participate in the hypothalamic
regulation of energy homeostasis and are responsive to
metabolic status [11–14]. Both cell types form protru-
sions that are in contact with blood capillaries, or the
ventricular surface in the case of tanycytes, and neurons,
thus enabling the transport and exchange of nutrients,
neurotransmitters and hormones. A responsiveness of
these non-neuronal cells to whole-body energy status is
indicated by data showing hypothalamic gliosis and in-
creased Gfap expression in genetically or diet-induced
obese models [15–20]. Furthermore, recent work has
highlighted a role for tanycytes as neural progenitor cells
that contribute to the hypothalamic energy homeostasis
regulating network [21–24]. Different subsets of tany-
cytes show a neurogenic response to specific signalling
factors as well as to a high-fat diet [24–28].
The Gnas locus, which encodes variants of the G-
protein α-stimulatory subunit (Gαs), is involved in the
hypothalamic regulation of energy balance [29]. The
locus consist of a complex arrangement of protein-
coding and non-coding transcripts, which are expressed
from alternative promoters (Fig. 1) [30, 31]. In addition
to the well-known Gαs protein, an NH2-terminal variant
(extra-large αs; XLαs) is expressed from a separate pro-
moter and transcript (Gnasxl). Both proteins stimulate
cAMP production after activation of seven-transmembrane
receptors, but XLαs can also exert a Gαq/11-like function
and increase inositol 1,4,5-trisphosphate signalling in some
cell types [32, 33]. The Gnas locus is epigenetically regu-
lated by a mechanism termed genomic imprinting, which
results in monoallelic gene expression according to paren-
tal origin [30]. DNA methylation acquired in the female
germline silences the expression of Gnasxl on the mater-
nally inherited allele. By contrast, Gnas remains biallelically
expressed in most tissues of the offspring, apart from a few
cell types, including specific brain regions, in which the pa-
ternally inherited Gnas allele is silenced (Fig. 1) [29–31].
Due to the monoallelic expression of these transcripts,
heterozygous knock-out (KO) mutations were used to
analyse the roles of Gnas and Gnasxl in energy homeosta-
sis, which revealed opposite phenotypes [29, 34]. Brain-
Fig. 1 Simplified scheme of the imprinted Gnas locus. The Gnas and
Gnasxl transcripts, which encode the Gαs and XLαs proteins, respectively,
are shown with their alternative promoters and splicing arrangements.
Promoter activities on the two parental alleles are indicated by arrows.
Gnasxl expression is suppressed by DNA methylation (MMM) on the
maternal allele. Gnas is biallelelically expressed in most tissues, but
silenced on the paternal allele is some cell types (hatched box and
arrow). For simplicity, other features of the locus, e.g. non-coding
RNAs, are not shown
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specific knock-out of Gnas expression from the maternal
allele results in obesity due to disrupted melanocortin re-
ceptor/Gαs signalling and consequently reduced energy
expenditure [35, 36]. By contrast, deletion of Gnasxl ex-
pression (from the paternal allele, Gnasxlm+/p-) causes a
lean and hypermetabolic phenotype associated with in-
creased energy expenditure and elevated SNS activity
[37–39]. This phenotype of adult KO mice follows an im-
paired postnatal development, which is characterised by
growth retardation, reduced feeding, hypoglycaemia and
lack of adipose reserves [38]. XLαs is expressed in defined
regions of the brain at neonatal and adult stages; its neo-
natal expression in some peripheral tissues is, however,
down-regulated towards weaning [32, 38–40]. Within the
hypothalamus, Gnasxl is present in neurons of the Arc,
DMH, PVH, lateral hypothalamus and the suprachiasmatic
nucleus (SCN) [40]. It is currently unclear how Gnasxl
functions within the neural energy homeostasis network,
which receptor(s) might signal via XLαs in the brain, and
whether the postnatal development of the hypothalamic
network might be impaired as a consequence of the neo-
natal undernutrition experienced by Gnasxlm+/p- pups.
Whole transcriptome sequencing (i.e., RNAseq) has
been shown to have many advantages for gene expression
profiling when compared to microarrays [41], including in
the context of the rodent brain [42]. Taking an unbiased
approach to analyse gene expression changes in hypothal-
ami of Gnasxl-deficient mice via RNAseq, we identified a
2-fold down-regulation of the glial marker Gfap. This un-
expected finding was confirmed by histological analyses of
adult hypothalami, which showed reduced Gfap-positive
cell numbers, while initial glial development at neonatal
stages was not different. The loss of glial cells in adult
hypothalami appears to be a consequence associated with
the lean Gnasxl-deficient phenotype, and our observations
complement opposite findings of gliosis in obese mouse
models. Furthermore, we show not only astrocytes, but
also Gfap-expressing α-tanycytes to be diminished. Since
α-tanycytes have a role as neural progenitor cells, our data
point towards potentially more far-reaching impacts on
the development or maintenance of the hypothalamic
energy homeostasis network.
Results
Transcriptome analysis indicates reduced Gfap expression
in hypothalami of Gnasxl-deficient mice
To take an unbiased approach to screen for changes in
gene expression in hypothalami of lean and hypermetabolic
Gnasxlm+/p- mice, we undertook a RNAseq transcriptome
analysis using the Illumina platform. Hypothalamus RNA
from 6 Gnasxlm+/p- mice and 6 WT littermates was iso-
lated and two samples of identical genotype were com-
bined to obtain a total of 3 Gnasxlm+/p- and 3 WT RNA
sample pools for library preparations and sequencing. The
six resulting sequencing files were mapped individually
using TopHat 2.0.4 to the mm10 build of the mouse gen-
ome. Using the Cufflinks package 2.0.2, we identified a
total of 332 significantly differentially expressed genes
(Additional file 1; Gene Expression Omnibus (GEO) acces-
sion number GSE75878). Most of these changes were
within the range from 4-fold increase to 4-fold decrease, al-
though some small nucleolar RNAs showed particularly
high fold-changes (Additional file 1). Notably Gnasxl RNA,
which is lost in the KO mice [38], was not identified as
differentially expressed. This is most likely due to the com-
plex structure of the Gnas locus with its transcript-specific
alternative promoters and mostly shared exons [30, 31],
which are difficult to resolve. To analyse the dataset of
differentially expressed genes further for association with
common processes and pathways [41], a functional enrich-
ment analysis was undertaken and revealed statistically sig-
nificant enriched categories amongst overexpressed genes
related to two broad categories: ribosomes, rRNA binding
and translation; and mitochondria and electron transport
chain (Additional file 2). No statistically significant categor-
ies were found amongst down-regulated genes after cor-
recting for multiple hypotheses testing (Additional file 2).
From the RNAseq list of genes (Additional file 1), we se-
lected a subset, which have been implicated in the litera-
ture with hypothalamic regulation of energy homeostasis,
for further verification by qRT-PCR. The candidate
gene Glial fibrillary acidic protein (Gfap) showed a
similar 2-fold down-regulation by RNAseq and qRT-PCR
(Gnasxlm+/p- RNAseq fold change: 0.48 ± 0.04 SEM, p <
0.0001, n = 3 per genotype; qRT-PCR fold change: 0.46 ±
0.18 SEM; p < 0.05, n = 3 per genotype) (Fig. 2). Since this
down-regulation of hypothalamic Gfap RNA in lean and
hypermetabolic Gnasxlm+/p- mice contrasts with the
up-regulation and gliosis found in obese mouse
models [15–20], we decided to further investigate Gfap
protein expression on the histological level.
Reduced glial cell numbers in adult, but not postnatal,
hypothalami of Gnasxlm+/p- mice
To assess the localisation and number of hypothalamic
Gfap-positive cells, immunohistochemistry (IHC) was
carried out on brain sections from adult Gnasxl WT and
KO littermates. Apart from astrocytes, Gfap was found
to be expressed in a subset of periventricular tanycytes
and their processes, which extend from the surface of
the 3rd ventricle into the hypothalamic parenchyma
(Fig. 3, Fig. 5 and Fig. 6) [14]. Only the α1 and α2 sub-
populations, which are located along the dorsal ventricle
and the Arc, were found to express Gfap [14, 27, 28].
The β1 and β2 tanycytes, which line the ventral ventricle
along the infundibular recesses and ME, respectively,
were negative for the glial marker. In Gnasxlm+/p- sam-
ples, we found fewer Gfap-positive cells in all areas
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along the rostro-caudal and dorso-ventral axes of the
hypothalamus, including the PVH, DMH, Arc, ME and
PH (Fig. 3a–f ). Quantification indicated a 41 % reduc-
tion in Gfap-positive cell numbers in posterior areas of
the hypothalamus (WT = 305 ± 21 vs KO = 179 ± 23
cells/section ± sem, ***p < 0.001, t-test, n = 11 matched
pairs of sections from 5 WT and 5 KO mice), while an-
terior and central regions showed 26 % fewer glial cells
(WT = 1110 ± 42 vs KO = 937 ± 35 cells/section ± sem,
**p < 0.01, t-test, n = 11 matched pairs of sections from 5
WT and 5 KO mice) (Fig. 3g). In the anterior hypothal-
amus, the suprachiasmatic nucleus (SCN) also contained
fewer Gfap-positive astrocytes (Fig. 4). To investigate
whether a reduced number of Gfap-expressing cells is
specific to the hypothalamus or occurs generally through-
out the brain, we additionally assessed cell numbers in the
hippocampus. We found no significant difference in this
brain region (WT= 769 ± 16 vs KO= 746 ± 19 cells/sec-
tion ± sem, p > 0.05, t-test, n = 15 matched pairs of sections
from 5 WTand 5 KO mice) (Additional file 3). These find-
ings indicate that a reduction in Gfap expression and glial
cell numbers is a characteristic feature of the hypothal-
amus area of Gnasxlm+/p- brains.
Since Gnasxl is expressed in hypothalamic neurons,
but not in glia or the ependymal layer of the hypothal-
amus (Additional file 4) [40], the reduction in Gfap-
expressing cells in the adult KO samples appears to be a
consequence of Gnasxl deficiency and an adaptation to
the severe postnatal undernutrition phenotype of
Gnasxlm+/p- pups [38, 39]. As glial cell differentiation
follows neuronal differentiation and mainly occurs at
late embryonic and early postnatal stages [14, 43], we
investigated whether this reduction in hypothalamic
Gfap-positive cells has a postnatal onset. Histological
comparison of Gfap expression in hypothalami of post-
natal day 15 (P15) samples did not, however, show a
significant difference in cell numbers between the two
genotypes (Fig. 5) (WT = 382 ± 25 vs KO = 440 ± 34
cells/section ± sem, n.s. p > 0.05, t-test, n = 33 matched
pairs of sections from 3 WT and 3 KO). Earlier postnatal
stages (P1, P5 and P10) showed overall lower numbers
of Gfap-positive cells, but no difference was found be-
tween WT and KO samples (data not shown). These find-
ings indicate that deficiency of Gnasxl does not impact on
the initial formation and differentiation of glial cells, but
that their reduction in adult hypothalami is a consequence
of the KO phenotype, which includes postnatal growth
retardation and undernutrition (hypoglycaemia, hypolipi-
demia) as well as increased metabolic rate driven by
elevated SNS activity during adult stages [37–39].
Loss of α-tanycytes and their processes
From the Gfap-IHC (Fig. 3) it appears that not only
astrocytes are affected, but also the α-subset of tany-
cytes. α-tanycytes facilitate the exchange of nutrients
and signalling molecules through their long processes,
which are in contact with the ventricular surface and
bridge to neurons and blood vessels far into the hypo-
thalamic parenchyma [14]. Furthermore, recent reports
have associated α-tanycytes with adult neural progenitor
cell functions [14, 24, 27, 28]. To further investigate the
effect of Gnasxl-deficiency on this cell type, we under-
took IHC for the intermediate filament Vimentin, which
is a marker for all tanycytes as well as ependymocytes
[27]. We found a strong reduction in Vimentin-positive
tanycyte processes specifically in the α-subset of tany-
cytes, while the β-subpopulation appeared normal
(Fig. 6). Lack of Gfap and Vimentin staining largely co-
incided in the Gnasxlm+/p- samples, which points to a
loss of many of the double-positive α-tanycyte pro-
cesses after postnatal day 15 and is in accordance with
the reduced number of Gfap-positive cell bodies (Fig. 3).
Remaining Vimentin-positive cells without processes
located in the ependymal layer of the α-tanycyte region
most likely represent ependymocytes [27]. In line with
these findings, a trend towards reduced vimentin gene
expression, although not significant, was observed in
Fig. 2 Reduced Gfap RNA expression levels in Gnasxlm+/p- hypothalami.
A similar 2-fold down-regulation of Gfap RNA levels was found by
RNAseq and qRT-PCR in Gnasxl knock-out hypothalami (***p < 0.0001;
*p < 0.05; Student’s independent t-test; n = 3 WT and 3 KO pools of
RNA with each pool consisting of two individual samples of the
same genotype)
Holmes et al. Molecular Brain  (2016) 9:39 Page 4 of 13
the RNAseq analysis of whole hypothalamus lysates
(Additional file 1). Additional investigations into the
expression pattern of the neural progenitor cell marker
Nestin showed a localised reduction of the protein in
the region of α-tanycytes (Fig. 7), similar to the changes
observed for Vimentin. Whether these changes in the
α-tanycyte population impact on neural progenitor
cell functions [14, 24, 27, 28] and hypothalamic net-
work maintenance in Gnasxlm+/p- mice remains to be
determined.
Astrocytes and tanycytes express specific solute trans-
porter proteins for glucose (Slc2a1/Glut1) and excita-
tory amino acids (Slc1a2/Glt1 and Slc1a3/Glast1), thus
regulating their availability and exchange between
compartments of the hypothalamic microenvironment
[14, 44, 45]. Despite the cellular changes described
above we did, however, not detect a reduction in ex-
pression levels of these transporter genes in whole
hypothalamus lysates of Gnasxlm+/p- mice by RNAseq
analysis or qRT-PCR (Additional files 1 and 5), which
G
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Fig. 3 Lower Gfap-positive cell counts in hypothalami of adult Gnasxlm+/p- mice. IHC for Gfap on coronal brain sections from WT (a, c, e) and KO
(b, d, f) littermates at different rostro-caudal levels. In addition to astrocytes, the α-subset of ependymal tanycytes and their processes (white arrows)
were found to express Gfap. a and b Anterior-dorsal hypothalamus at the level of the Paraventricular Nucleus (PVH). c and d Central-ventral
hypothalamus at the level of the Arcuate Nucleus (Arc). e and f Level of the posterior hypothalamus (PH). Scale bar = 100 μm. g Quantification of
Gfap-expressing cells at the anterior-central and posterior levels, respectively, (anterior & central: WT = 1110 ± 42 vs KO = 937 ± 35 cells/section ± sem,
**p < 0.01, t-test, n = 11 matched pairs of sections from 5 WT and 5 KO mice; posterior: WT = 305 ± 21 vs KO = 179 ± 23 cells/section ± sem,
***p < 0.001, t-test, n = 11 matched pairs of sections from 5 WT and 5 KO mice)
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might be due to compensatory up-regulation in the
remaining glial cell population.
Discussion
The unbiased assessment of gene expression changes in
hypothalami of adult Gnasxl-deficient mice via RNAseq
revealed a 2-fold down-regulation of the glial marker
Gfap, and further histological examination indicated
reduced numbers of Gfap-positive astrocytes and α-
tanycytes. These findings were unexpected, since Gnasxl
is not expressed in glial cells or in the ependymal layer
of the 3rd ventricle, but is present in neurons of the Arc,
DMH, PVH, lateral hypothalamus and the SCN [40].
Furthermore, Gfap-positive cell numbers were not di-
minished at postnatal stages, when the developmental
process of glia and tanycyte differentiation reaches com-
pletion in mice [14, 43, 46, 47]. This indicates that the
initial formation of these cell types is not impaired by
lack of XLαs, but that their reduction in adult hypothal-
ami must be a consequence of the phenotype of the
Fig. 4 Fewer Gfap-expressing astrocytes in the suprachiasmatic nucleus
(SCN). Gfap-immunofluorescence (green) in the SCN of two adult WT
and Gnasxlm+/p- littermates (nuclear stain: DAPI). Images taken at original
magnification 100 x
Fig. 5 Glial cell numbers are not different in hypothalami of postnatal Gnasxlm+/p- mice. Gfap IHC on postnatal day 15 brain sections from WT
(a and c) and KO (b and d) littermates. a and b Anterior-dorsal hypothalamus at the level of the PVH; (c and d) central-ventral hypothalamus
at the level of the Arc. Scale bar = 100 μm. e Quantification of Gfap-positive cells: WT = 382 ± 25 vs KO = 440 ± 34 cells/section ± sem, p > 0.05, t-test,
n = 33 matched pairs of sections along the rostro-caudal axis of the hypothalami of 3 WT and 3 KO mice
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Gnasxl KO mice, which comprises post-natal under-
nutrition, continued hypoglycaemia, reduced body weight
and fat mass as well as hypermetabolism [38, 39].
It is remarkable in this context that nutritional pro-
gramming in rats, i.e. postnatal under-nutrition, results
in adult offspring with a very similar phenotype to
Gnasxl-deficient mice, including reduced body weight
and fat mass, transformation of white adipose tissue to
metabolically stimulated ‘brown-like’ adipose tissue and
hypoleptinemia [8–10, 38, 39]. However, changes in
hypothalamic neuronal networks have been little analysed
at the histological level in rodent models of postnatal un-
dernutrition [48], and glial or tanycyte abnormalities have
not been reported so far. In support of our findings in
Gnasxlm+/p- mice, some studies on the effects of foetal
and/or postnatal protein restriction and malnutrition
described similar reductions in Gfap expression and glial
cell numbers in the suprachiasmatic nucleus and the
medial preoptic area [49, 50]. By contrast, genetic or diet-
induced mouse models of obesity have been much better
characterised for changes in the hypothalamus. Specific-
ally, observations of gliosis and increased Gfap expression
in obese mice contrast with the glial effects we identified
in lean Gnasxl KOs [15–20]. The gliosis observed in obese
mice leads to increased glial ensheathment and reduced
numbers of synapses on POMC and NPY neurons in the
Arc [18]. Whether, correspondingly, glial processes sur-
rounding hypothalamic neurons in Gnasxl-deficient mice
are reduced remains to be determined on an ultrastruc-
tural level. Any consequences of such glial changes on the
activity of the neural network regulating energy homeosta-
sis are only beginning to be explored, although in obese
mice a reduced inhibitory synaptic input on POMC neu-
rons was detected [17, 18].
Fig. 6 Loss of α-tanycytes. Co-immunofluorescence for the tanycyte marker Vimentin and for Gfap on (a) central and (b) posterior hypothalamic
sections of WT and Gnasxl-deficient mice. White arrows mark the general localisation of α-tanycytes, most of which co-express both markers.
Asterisks indicate the regions of Gfap-negative, Vimentin-positive β-tanycytes. While double-positive α-tanycyte extensions and cell bodies are
strongly reduced, β-tanycytes appear unaffected in the KO mice. White arrowheads indicate remaining Gfap/Vimentin double-positive α-tanycyte
processes in the KO samples. The white rectangle on the DAPI images in (a) indicates the position of the higher magnification Gfap/Vimentin images.
Scale bars represent 100 μm
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A loss of Gfap expression in Gnasxl KO mice was es-
pecially evident in the α-subset of tanycytes, which are
part of the ependymal layer lining the 3rd ventricle along
the Arc, ventromedial hypothalamus and DMH [14].
The β-subset of tanycytes, which is located more ven-
trally along the infundibular recesses of the 3rd ventricle
and the ME, does not express Gfap, but both subsets are
marked by expression of Vimentin [13, 14, 27, 28].
While Vimentin IHC of β-tanycytes and their processes
appeared undiminished in Gnasxlm+/p- mice, it was reduced
in a similar pattern to Gfap in the α-tanycyte subset.
Few double-positive α-tanycyte processes remained.
Some Vimentin-positive/Gfap-negative cells without
processes were still detectable in the ependymal layer
of the α-tanycyte region of Gnasxl KOs, which most
likely represent Vimentin-expressing ependymocytes
[27]. Although we also detected a trend towards re-
duced vimentin gene expression in the RNAseq ex-
periment, this was not significant in the context of
lysates from whole-hypothalamus samples. Overall, these
data indicate that a substantial proportion of α-tanycytes
have been lost in the hypothalamus of Gnasxl-deficient
adult mice.
Two major functions of α-tanycytes have been charac-
terised. With their processes these cells bridge the epen-
dymal border of the 3rd ventricle with the Arc, VMH
and DMH and are capable of transporting substrates
from the cerebrospinal fluid into the hypothalamic par-
enchyma [11, 13, 14]. It was shown that α-tanycytes ex-
press glucose transporters and are sensitive to changes
in extracellular glucose concentration, thus implicating
them as a functional component in the hypothalamic
network that regulates energy homeostasis [11, 13]. We
did not detect changes in glial transporter gene expres-
sion in our RNA samples from whole hypothalami,
which could be due to compensatory up-regulation in
the remaining cells. However, at this stage we cannot
exclude disturbances in localised nutrient or neurotrans-
mitter transport or availability.
Recent reports have shown that tanycytes also possess
neural progenitor cell functions [13, 21, 23]. Both, β- as
well as α-tanycytes can proliferate and generate neurons
Fig. 7 Reduced expression of Nestin in α-tanycyte region. Immunohistochemistry for the neural progenitor cell marker Nestin shows reduced expression
in the region of α-tanycytes (arrows), but no difference in the more ventrally located β-tanycyte population. Pairs of images from three different WT and
Gnasxlm+/p- adult littermates are shown for medial (a, b) to posterior (c, d, e, f) positions of the hypothalamus. Scale bars indicate 100 μm
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and to some extent glial cells, although β-tanycytes ap-
pear to exert this function mainly during juvenile stages
and show less proliferation during adulthood [25, 26]. By
contrast, α-tanycytes were shown to self-renew and give
rise to neurons and glial cells at adult stages, and this
process was specifically stimulated by fibroblast growth
factors (FGFs) and insulin-like growth factor 1 (IGF-1)
[24, 27, 28]. Some α-tanycytes co-express Gfap and the
neural stem cell transcription factor Sox2 [28], which
showed a trend towards reduced expression levels in our
RNAseq analysis of Gnasxl KO samples (Additional file 1).
For another marker of neural progenitor cells, the
intermediate filament protein Nestin, insufficient se-
quence reads were obtained in the RNAseq analysis,
most likely due to low Nestin RNA levels, but it was de-
tectable histologically in the ependymal layer. Nestin
protein expression appeared to be reduced specifically
at the level of α-tanycytes, similar to Vimentin and
Gfap. This finding further supports the view that the α-
tanycyte-associated neural progenitor cell population
has been impacted. However, a functional assessment
of hypothalamic stem cells in Gnasxl deficient mice
and any consequences of a partial loss of α-tanycytes
on neural cell maintenance in the hypothalamus remain
to be determined. Taking into account the nutritional
programming effects discussed above, it can also not be
excluded that postnatal undernutrition, either diet-
induced [8–10] or as described in our genetic model
[38, 39], results in additional changes in the hypothal-
amic network that regulates energy homeostasis. Future
investigations will be aimed at assessing cell proliferation
and potential changes in the proportions of specific
neuron types in the hypothalamus, for example NPY and
POMC neurons in the Arc.
The direct function of Gnasxl on a cellular and mo-
lecular level in neurons of the brain remains currently
unclear. Although the XLαs protein has been shown to
couple activated receptors to the cAMP signalling path-
way in cell lines [33] and can also mediate Gq/11-like IP3
signalling in renal proximal tubules [32], the physio-
logical relevant receptors in the brain have not yet been
identified. Lack of XLαs leads to severe postnatal under-
nutrition and failure to grow, which is associated with a
high pre-weaning mortality [38]. KO mice that survive
into adulthood show increased SNS activity, which causes
an elevated basic metabolic rate, body temperature and
cardiovascular parameters [37, 39]. Taking into account
the data presented here, it appears now likely that the
phenotype of Gnasxlm+/p- mice that survive into adult-
hood needs to be considered as a composite of direct
effects related to lack of XLαs signalling in neurons, as
well as adaptions in the hypothalamic neural network,
including astrocytes and α-tanycytes, which occur in re-
sponse to the severe postnatal undernutrition of the
mutant mice. The RNAseq data generated as part of this
work will be a useful resource for comparisons with other
nutritional programming studies, as well as for further in-
vestigations into the functions of Gnasxl in the hypothal-
amus. Additionally, the Gnasxl KO mouse model could
have relevance to human in both aspects: in the context of
rare genetic neonatal growth disorders that are associated
with loss of GNASXL at chromosome 20q13 [51–55], and
as a model to investigate the consequences of neonatal
undernutrition on programming of energy homeostasis in
human adult life [56].
Conclusions
Lean and hypermetabolic Gnasxl-deficient mice show
reduced expression levels of the glial marker Gfap, as
well as a reduction in astrocyte and α-tanycyte numbers
in the hypothalamus at adult stages. The findings that
the changes are not present at postnatal stages when
these glial cell types are completing their development
and, furthermore, that Gnasxl is not expressed in these
cell types, lead us to conclude that the hypothalamic
changes are an adaptation or consequence of the severe
neonatal undernutrition the KO mice experience. The
adult phenotype of Gnasxl KO mice, which includes
increased metabolic rate, reduced fat mass, increased
glucose tolerance and insulin sensitivity, as well as ele-
vated SNS activity, is reminiscent of rodent models of
metabolic programming through postnatal undernutri-
tion. The phenotype of adult Gnasxl-deficient mice,
therefore, appears to be a combination of lack of XLαs
signalling in neurons, as well as adaptations in the hypo-
thalamic network that regulates energy homeostasis and
which includes astrocytes and α-tanycytes.
Methods
Animal care
The Gnasxlmouse line [38] was maintained on a CD1 out-
bred background. Gnasxl-deficient offspring (Gnasxlm+/p−),
which lack XLαs expression from the paternally inherited
allele, was produced by mating CD1 females with Gnasxl
mutation-carrying males. Mice were maintained in the
animal facility of the University of Liverpool on a 12 h light
– 12 h dark cycle and had unlimited access to water and
standard chow diet. All animal work was approved by the
Animal Welfare and Ethical Review Body of the University
of Liverpool and carried out in accordance with the UK
Animals (Scientific Procedures) Act 1986 (UK Home
Office Project Licence PPL40/3577) and the directive
2010/63/EU for Europe.
RNA seq and bioinformatics analyses
Hypothalami were dissected from 6 Gnasxlm+/p- and 6 WT
littermates (six months old females). Hypothalamic total
RNA was isolated using a Qiagen RNeasy Plus Mini kit.
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The quality of the RNA was confirmed on a Bioanalyzer
2100 (Agilent Technologies) with a RNA Integrity Number
of 8.5 or higher for all samples. For cost effectiveness, but
to retain biological sample variability, RNA from two
Gnasxlm+/p- and two WT samples were pooled, respect-
ively, to obtain a total of 3 Gnasxlm+/p- and 3 WT RNA
pools. Ribosomal RNA (rRNA) was removed from each
pool using the Ribominus Eukaryote Kit for RNA‐Seq (Life
Technologies), and 95–98 % depletion of rRNA was con-
firmed on a Bioanalyzer 2100. Before library preparation,
the RNA sample concentrations were quantified on a
Qubit (Life Technologies) using Ribogreen. For each
pooled sample, 50 ng of RNA was used for library prepar-
ation using the ScriptSeq v2 RNA‐Seq Library Preparation
Kit (Epicentre). Briefly, the RNA was first fragmented at
85 °C for 5 min, random hexamer cDNA synthesis primers
with tagging sequences for Illumina sequencing slides were
annealed and cDNA prepared using StarScript Reverse
Transcriptase. cDNA was purified using the Agencourt
AMPure XP system (BeckmanCoulter) and then amplified
with ScriptSeq Index PCR Primers (Epicentre), in order to
reduce representation bias during multiplex sequencing.
Suitable size distribution of the library preparations were
confirmed using the Bioanalyzer 2100. Pair-end sequencing
(2 x 100 bp reads) of barcoded samples was carried out by
the Centre for Genomic Research (University of Liverpool,
UK) using an Illumina Genome Analyzer IIx (GAIIx). The
data were quality-controlled using a filter for CHASTITY ≥
0.6 and demultiplexed using the Illumina CASAVA 1.8.2
pipeline. A further quality control analysis was then per-
formed using FastQC (Babraham Bioinformatics). Both
sense and anti‐sense FASTQ files were mapped to the
mm10 build of the M. musculus genome (UCSC genome
browser) using TopHat 2.0.4., incorporating a repeatmask
(RepeatMasker) [57]. Of the approximately 28 million
reads per sample generated, 40 % were mapped to the
mouse genome. Data were then analysed using Cufflinks,
Cuffcompare and Cuffdiff (version 2.0.2) with multiple hy-
potheses correction [58] to the GTF transcript annotation
file provided by Illumina iGenomes, to examine differential
expression between Gnasxlm+/p- and WT samples. RNAseq
data files have been deposited at Gene Expression
Omnibus (GEO) database under accession number
GSE75878 (see also Additional file 1). Functional enrich-
ment analysis was performed in the DAVID bioinformat-
ics resources [59] using the whole mouse genome as
background and default parameters. Full results, including
p-values after correcting for multiple hypotheses testing,
are available in Additional file 2.
qRT-PCR
Quantitative RT-PCR was carried out on the same three
pooled WT and three pooled Gnasxlm+/p- total RNA sam-
ples that had been used for the RNAseq experiments.
cDNA was synthesised using MMLV Reverse Transcript-
ase (Life Technologies) and real-time PCR was performed
using the Brilliant II SYBR Green QPCR Master Mix with
Low Rox (Agilent Technologies) on an Applied Biosys-
tems 7500 Fast Real‐Time PCR System. Relative quanti-
fication was calculated through normalisation to two
housekeeping genes, β-Actin (Actb) and Cyclophilin A
(Ppia), using the Applied Biosystems 7500 software.
Primer efficiencies were evaluated on a five-fold dilu-
tion series of cDNA and only primer pairs with 93–
107 % efficiency and a R2 > 0.98 were used for relative
quantification. The following primer pairs were used: Actb:
For 5’-GCTTCTTTGCAGCTCCTTCGT-3’, Rev 5’-
ATATCGTCATCCATGGCGAAC-3’; Ppia: For 5’-
CAAATGCTGGACCAAACACAA-3’, Rev 5’-GCCATC-
CAGCCATTCAGTCT-3’; Gfap: For 5’-ACCAGCT-
TACGGCCAACAGT-3’, Rev 5’-CCGAGGTCCTGTG
CAAAGTT-3’. Glial solute transporter gene expression
was assessed separately on a Biorad CFX Connect instru-
ment using iTaq Universal SYBR Green Supermix re-
agents (Bio-Rad Laboratories). Hypothalamic RNA from
six adult WT and six Gnasxlm+/p- littermates was used.
Target gene data were normalised to two housekeeping
genes, β-Actin (Actb) and Beta-2-microglobulin (B2m),
and relative expression was calculated via the ΔCt
method. The following primer pairs were used: Actb: For
5’-GGCTCCTAGCACCATGAAGATC-3’, Rev 5’-
ACATCTGCTGGAAGGTGGACA-3’; B2m: For 5’-ATT-
CACCCCCACTGAGACTG-3’, Rev 5’-GTCTCGATCC-
CAGTAGACGG-3’; Slc2a1: For 5’-CTCACCACGCT
TTGGTCTCT-3’, Rev 5’-CCCAGTTTGGAGAAGCC-
CAT-3’; Slc1a2: For 5’-ATCACTGCTCTGGGAACTGC-
3’, Rev 5’-ACGAATCTGGTCACACGCTT; Slc1a3: For 5’-
GAGAGATTGCAGCAAGGGGT-3’, Rev 5’-ATACGGTC
GGAGGGCAAATC-3’.
Immunohistochemistry
For IHC, transcardiac perfusion was carried out on 5 WT
and 5 Gnasxlm+/p- (KO) littermates (2-4 months old fe-
males), brain tissues were further fixed overnight in 4 %
PFA/PBS and then dehydrated in 30 % sucrose/PBS. Post-
natal brains were fixed without perfusion. 12 μm brain sec-
tions were prepared on a Leica CM 1950 cryostat. Sections
were treated for antigen retrieval by submerging slides in
10 mM sodium citrate at 60 °C for 2 min and endogenous
peroxidase activity was quenched by submerging section in
methanol/0.3 % H2O2 for 5 min. Sections were blocked with
PBS/10 % goat serum/0.25 % Triton-X100, incubated over-
night with rabbit polyclonal anti-Gfap (Dako, Z0334,
1:3000) or mouse monoclonal anti-Nestin (BD Pharmin-
gen, 556309, 1:100) antibody and developed using the
VECTASTAIN Elite ABC Kit (Vector Laboratories) with
3,3’-diaminobenzidine substrate. Stained sections were
dehydrated, permanently mounted in Eukitt (Fluka
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Analyticals) and imaged on a Leica microscope and LAS
software (Leica Microsystems). Hypothalamic Gfap cell
counts were obtained using ImageJ from images taken at
100 x magnification, whereby the 3rd ventricle was posi-
tioned at the centre of the image. All areas along the
dorso-ventral axis of the hypothalamic ventricle were in-
cluded at equal left-right distance from the midline. Sec-
tions covered the rostro-caudal axis of the hypothalamus
corresponding to the mouse brain atlas plates 36–50
(Bregma -0.58 mm to -2.30 mm) [60], including the PVH,
ME, Arc, VMH, DMH and PH. Images from WT and KO
littermates that matched to the same atlas plate were
paired and processed for comparative glial cell counts. In
total, 22 pairs of sections from the 5 WT/5 KO adult
brains were included. For postnatal day 15, Gfap cell num-
bers were established from 33 pairs of sections from 3
WT/3 KO littermates from two litters. Images of adult
hippocampus Gfap expression were taken from the same
series of stained sections as the hypothalamus images,
covering the mouse brain atlas plates 41–49 (Bregma
-1.22 to -2.18 mm) [60]. In total, 15 pairs of sections from
5 WT/5 KO mice were analysed. For immunofluores-
cence, the same anti-GFAP and a chicken anti-Vimentin
antibody (Millipore, AB5733, 1:4000) were used, com-
bined with Alexa Fluor 488 donkey anti rabbit (Life Tech-
nologies) and DyLight 594 donkey anti-chicken (Jackson
ImmunoResearch Laboratories) secondary antibodies
(1:2000).
Statistical analyses
Hypothalamic cell counts and qRT-PCR data were ana-
lysed by Student’s independent t-test. RNAseq statistical
analysis was undertaken as described above. P-values in
Additional file 1 are derived from the corresponding q-
values following multiple hypotheses correction. All graphs
show data as means ± SEM.
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Additional files
Additional file 1: RNAseq list of gene expression changes in
hypothalamus samples from Gnasxlm+/p- mice versus WT littermates.
Genes are listed by their log2(fold change) from most up-regulated to
most down-regulated. (XLSX 5507 kb)
Additional file 2: Functional enrichment analysis using the DAVID
bioinformatics resources. The whole mouse genome was used as background
with default parameter settings. Full results, including p-values after correcting
for multiple hypotheses testing, are shown. Statistically significant enriched
categories amongst overexpressed genes related to the two broad categories
of ‘ribosomes/rRNA binding and translation’ and ‘mitochondria/electron
transport chain’. Amongst the down-regulated genes no statistically significant
categories were found. (XLSX 166 kb)
Additional file 3: Gfap expression in the hippocampus of adult Gnasxl-
deficient mice is not changed. IHC for Gfap on coronal brain sections
from WT (A, C, E) and KO (B, D, F) littermates at different rostro-caudal
levels. In contrast to the hypothalamus, quantification of Gfap-expressing
cells in the hippocampal areas did not show any significant difference
(WT = 769 ± 16 vs KO = 746 ± 19 cells/section ± sem, p > 0.05, t-test, n = 15
matched pairs of sections from 5 WT and 5 KO mice). Scale bar = 100 μm.
(PDF 731 kb)
Additional file 4: Gnasxl is not expressed in the ependymal layer, but
the parenchyma of the hypothalamus. IHC (A) for XLαs (green) in the
postnatal day 1 (P1) hypothalamus and in situ hybridisation for Gnasxl at
P4 (B) show scattered positive cells in the DMH, but not in the ependymal
layer (ep) of the 3rd ventricle (DAPI nuclear counterstain). (C) Similarly, IHC
for XLαs in the adult hypothalamus marks neurons in the parenchyma,
but no expression is found in ependymal cells (arrow). XLαs is a membrane-
associated protein detectable in neurites, but no tanycyte extensions are
stained. Arc = arcuate nucleus, DMH = dorsomedial nucleus, ME =median
eminence. Scale bar = 100 μm. (PDF 619 kb)
Additional file 5: Expression levels of glial solute transporter genes in
hypothalami of adult Gnasxlm+/p- mice. qRT-PCR analyses did not detect
any significant changes in expression levels of the glucose transporter Slc2a1
(Glut1) or the excitatory amino acid transporters Slc1a2 (Glt1) and Slc1a3
(Glast1). (N = 6 WT and 6 KO samples; t-test, p > 0.05 n.s.). (PDF 273 kb)
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